JerusalemMan
Chris Perry
From the link I posted in the last page.Would be interesting to see how many blood clots occurred in 10million people who have received no vaccine at all so far as well, to see what the “normal” case rate is.
https://www.theguardian.com/comment...-oxford-vaccine-blood-clots-data-causal-links
Deep vein thromboses (DVTs) happen to around one person per 1,000 each year, and probably more in the older population being vaccinated. Working on the basis of these figures, out of 5 million people getting vaccinated, we would expect significantly more than 5,000 DVTs a year, or at least 100 every week. So it is not at all surprising that there have been 30 reports.
It would be so much easier if we had a group of people exactly like those being vaccinated but who didn’t get jabbed. This would tell us how many serious events we could expect to happen to people that were the result of sheer bad luck. Fortunately, we do have such a group. In the trials that led to the vaccines being approved in the UK, volunteers were randomly allocated to receive either the active vaccine or a control injection (some of which were a vaccine for meningitis). Everyone then reported any harms they experienced, but crucially nobody knew if they had received the real stuff. By comparing the numbers of reports from the two groups, we can see how many “reactions” were really owing to the active ingredients, and how many were linked to the vaccination process, or would have happened anyway.
Some kind of adverse events were reported by 38% of those receiving the real vaccine but, rather remarkably, 28% of those who received the control also reported a side-effect. This shows that the Covid vaccine itself only causes about a third of the reported side-effects. Of more than 24,000 participants, fewer than 1% reported a serious adverse event, and of these 168 people, slightly more had received the dummy than the active vaccine. So there was no evidence of increased risk from taking the AstraZeneca vaccine. The Pfizer trials had similar results, with more mild or moderate adverse events in the vaccine group but almost identical numbers of serious events.